πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 650 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7354579

Method of treating cancer with a VEGF antagonist and an anti-proliferative agent

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354894

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354582

Use of VEGF antagonists for the treatment of malignant gliomas

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354581

Therapeutic combination of a VEGF antagonist and anti-hypertensive agent

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7348324

Cyclic amine compounds as CCR5 antagonists

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7345060

Compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activit

Theravance, Inc. Β· Granted Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7329669

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7312231

Quinuclidine carbamate derivatives and their use as M3 antagonists

Almirall Prodesfarma S.A. Β· Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7300940

Integrin Ξ±-v Ξ²-3 antagonists for use in imaging and therapy

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7294344

Sustained-release preparation for AII antagonist, production and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7288657

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7273710

Method for screening MCH receptor antagonist/agonist

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7265133

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7262205

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7253171

Urea derivatives as integrin Ξ±4 antagonists

Laboratories Almirall, S.A. Β· Granted Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7252929

Methods for identifying alpha PDGFR agonists and antagonists

United State of America, As Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7250414

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jul 31 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7229986

Melanin-concentrating hormone antagonist

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7229995

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7211252

Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin an

The Board of Regents of the University of Texas System Β· Granted Tue May 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7208579

IL4 receptor antagonists for horse, dog and cat

The Regents of the University of California Β· Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7208515

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7208501

Quinuclidine carbamate derivatives and their use as M3 antagonists

Almirall Prodesfarma S.A. Β· Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7205411

Aminopyridine derivatives as mGluR5 antagonists

Addex Pharmaceuticals S.A. Β· Granted Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted